HEADER VIRAL PROTEIN 16-MAR-23 8GJN TITLE 17B10 FAB IN COMPLEX WITH UP-RBD OF SARS-COV-2 SPIKE G614 TRIMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAVY CHAIN OF 17B10 FAB; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: LIGHT CHAIN OF 17B10 FAB; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: SPIKE PROTEIN S2'; COMPND 11 CHAIN: C; COMPND 12 FRAGMENT: RBD; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 10 ORGANISM_COMMON: MOUSE; SOURCE 11 ORGANISM_TAXID: 10090; SOURCE 12 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 13 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 17 2; SOURCE 18 ORGANISM_TAXID: 2697049; SOURCE 19 GENE: S, 2; SOURCE 20 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 21 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 22 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR H.J.KWON,J.ZHANG,M.KOSIKOVA,W.C.TANG,U.O.RODRIGUEZ,H.Q.PENG, AUTHOR 2 C.A.MESEDA,C.L.PEDRO,F.SCHMEISSER,J.M.LU,B.ZHOU,C.T.DAVIS, AUTHOR 3 D.E.WENTWORTH,W.H.CHEN,M.C.SHRIVER,M.F.PASETTI,J.P.WEIR,B.CHEN,H.XIE REVDAT 3 19-APR-23 8GJN 1 JRNL REVDAT 2 12-APR-23 8GJN 1 JRNL REVDAT 1 05-APR-23 8GJN 0 JRNL AUTH H.J.KWON,J.ZHANG,M.KOSIKOVA,W.TANG,U.ORTEGA-RODRIGUEZ, JRNL AUTH 2 H.PENG,C.A.MESEDA,C.L.PEDRO,F.SCHMEISSER,J.LU,I.KANG,B.ZHOU, JRNL AUTH 3 C.T.DAVIS,D.E.WENTWORTH,W.H.CHEN,M.C.SHRIVER,R.S.BARNES, JRNL AUTH 4 M.F.PASETTI,J.P.WEIR,B.CHEN,H.XIE JRNL TITL DISTINCT IN VITRO AND IN VIVO NEUTRALIZATION PROFILES OF JRNL TITL 2 MONOCLONAL ANTIBODIES ELICITED BY THE RECEPTOR BINDING JRNL TITL 3 DOMAIN OF THE ANCESTRAL SARS-COV-2. JRNL REF J MED VIROL V. 95 28673 2023 JRNL REFN ISSN 1096-9071 JRNL PMID 36916782 JRNL DOI 10.1002/JMV.28673 REMARK 2 REMARK 2 RESOLUTION. 3.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : COOT, PHENIX, RELION, RELION, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 7KRR REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : AB INITIO MODEL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.600 REMARK 3 NUMBER OF PARTICLES : 439265 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8GJN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1000273050. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : 17B10 FAB IN COMPLEX WITH UP REMARK 245 -RBD OF SARS-COV-2 SPIKE G614 REMARK 245 TRIMER REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : 17B10 FAB IN COMPLEX WITH UP REMARK 245 -RBD OF SARS-COV-2 SPIKE G614 TRIMER REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2200.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5444.20 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 TRP A 3 REMARK 465 SER A 4 REMARK 465 TRP A 5 REMARK 465 ILE A 6 REMARK 465 PHE A 7 REMARK 465 LEU A 8 REMARK 465 PHE A 9 REMARK 465 LEU A 10 REMARK 465 LEU A 11 REMARK 465 SER A 12 REMARK 465 GLY A 13 REMARK 465 THR A 14 REMARK 465 ALA A 15 REMARK 465 GLY A 16 REMARK 465 VAL A 17 REMARK 465 LEU A 18 REMARK 465 SER A 19 REMARK 465 MET B 1 REMARK 465 ARG B 2 REMARK 465 VAL B 3 REMARK 465 PRO B 4 REMARK 465 ALA B 5 REMARK 465 HIS B 6 REMARK 465 VAL B 7 REMARK 465 PHE B 8 REMARK 465 GLY B 9 REMARK 465 PHE B 10 REMARK 465 LEU B 11 REMARK 465 LEU B 12 REMARK 465 LEU B 13 REMARK 465 TRP B 14 REMARK 465 PHE B 15 REMARK 465 PRO B 16 REMARK 465 GLY B 17 REMARK 465 THR B 18 REMARK 465 ARG B 19 REMARK 465 CYS B 20 REMARK 465 ASP B 21 REMARK 465 LYS C 529 REMARK 465 SER C 530 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN C 343 O5 NAG C 601 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 86 -23.56 -143.68 REMARK 500 LEU A 105 99.58 -68.16 REMARK 500 ASP A 109 62.53 -103.50 REMARK 500 VAL A 125 53.71 35.55 REMARK 500 ASP A 126 -64.94 -98.41 REMARK 500 LEU B 53 145.07 -172.84 REMARK 500 ASP B 61 52.13 -97.56 REMARK 500 ALA B 70 -142.97 57.10 REMARK 500 SER B 76 -124.52 51.44 REMARK 500 LYS B 80 -133.18 47.54 REMARK 500 CYS C 336 157.15 -47.98 REMARK 500 PRO C 337 48.00 -77.53 REMARK 500 VAL C 341 -60.79 -107.23 REMARK 500 ASN C 343 52.86 -113.90 REMARK 500 ASN C 422 -53.90 -129.61 REMARK 500 THR C 430 61.09 -103.07 REMARK 500 PHE C 464 19.30 56.84 REMARK 500 THR C 523 -54.47 -121.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-40095 RELATED DB: EMDB REMARK 900 17B10 FAB IN COMPLEX WITH UP-RBD OF SARS-COV-2 SPIKE G614 TRIMER DBREF 8GJN A 1 138 PDB 8GJN 8GJN 1 138 DBREF 8GJN B 1 127 PDB 8GJN 8GJN 1 127 DBREF 8GJN C 333 530 UNP P0DTC2 SPIKE_SARS2 333 530 SEQRES 1 A 138 MET GLY TRP SER TRP ILE PHE LEU PHE LEU LEU SER GLY SEQRES 2 A 138 THR ALA GLY VAL LEU SER GLU VAL GLN LEU GLN GLN SER SEQRES 3 A 138 GLY PRO GLU LEU VAL LYS PRO GLY ALA SER VAL ARG ILE SEQRES 4 A 138 SER CYS LYS THR SER GLY TYR THR PHE THR GLU TYR SER SEQRES 5 A 138 MET PHE TRP VAL LYS GLN SER HIS GLY GLN SER LEU GLU SEQRES 6 A 138 TRP ILE GLY GLY ILE ASN PRO ASN ASP ASP SER THR THR SEQRES 7 A 138 TYR LYS GLN ASN PHE LYS GLY LYS ALA THR LEU THR VAL SEQRES 8 A 138 ASP LYS SER SER SER THR ALA PHE MET GLU LEU ARG SER SEQRES 9 A 138 LEU THR SER GLU ASP SER ALA VAL TYR TYR CYS THR ARG SEQRES 10 A 138 ASP ARG TYR ASP GLY ARG VAL VAL ASP PHE TRP GLY GLN SEQRES 11 A 138 GLY THR THR LEU THR VAL SER SER SEQRES 1 B 127 MET ARG VAL PRO ALA HIS VAL PHE GLY PHE LEU LEU LEU SEQRES 2 B 127 TRP PHE PRO GLY THR ARG CYS ASP ILE GLN MET THR GLN SEQRES 3 B 127 SER PRO SER SER LEU SER ALA SER LEU GLY GLU ARG VAL SEQRES 4 B 127 SER LEU ILE CYS ARG ALA SER GLN GLU ILE SER GLY TYR SEQRES 5 B 127 LEU SER TRP LEU GLN GLN LYS PRO ASP GLY THR ILE LYS SEQRES 6 B 127 ARG LEU ILE TYR ALA ALA SER THR LEU ASP SER GLY VAL SEQRES 7 B 127 PRO LYS ARG PHE SER GLY SER ARG SER GLY SER GLU TYR SEQRES 8 B 127 SER LEU THR ILE SER SER PRO GLU SER GLU ASP PHE ALA SEQRES 9 B 127 ASP TYR TYR CYS LEU GLN TYR ALA SER TYR PRO TRP THR SEQRES 10 B 127 PHE GLY GLY GLY THR LYS LEU GLU ILE LYS SEQRES 1 C 198 THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR SEQRES 2 C 198 ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SEQRES 3 C 198 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER SEQRES 4 C 198 ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO SEQRES 5 C 198 THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA SEQRES 6 C 198 ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE SEQRES 7 C 198 ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN TYR SEQRES 8 C 198 LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP SEQRES 9 C 198 ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN TYR SEQRES 10 C 198 ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS SEQRES 11 C 198 PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA SEQRES 12 C 198 GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN CYS SEQRES 13 C 198 TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR ASN SEQRES 14 C 198 GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 15 C 198 PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO SEQRES 16 C 198 LYS LYS SER HET NAG C 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG C8 H15 N O6 HELIX 1 AA1 THR A 47 TYR A 51 5 5 HELIX 2 AA2 LYS A 80 GLY A 85 1 6 HELIX 3 AA3 PHE C 338 ASN C 343 1 6 HELIX 4 AA4 SER C 349 TRP C 353 5 5 HELIX 5 AA5 ASP C 364 ASN C 370 1 7 HELIX 6 AA6 SER C 383 ASP C 389 5 7 HELIX 7 AA7 GLU C 406 ALA C 411 5 6 HELIX 8 AA8 GLY C 416 ASN C 422 1 7 HELIX 9 AA9 SER C 438 SER C 443 1 6 SHEET 1 AA1 6 GLU A 29 LEU A 30 0 SHEET 2 AA1 6 THR A 132 THR A 135 1 O THR A 135 N GLU A 29 SHEET 3 AA1 6 ALA A 111 ASP A 118 -1 N TYR A 113 O THR A 132 SHEET 4 AA1 6 SER A 52 GLN A 58 -1 N GLN A 58 O VAL A 112 SHEET 5 AA1 6 LEU A 64 ASN A 71 -1 O GLU A 65 N LYS A 57 SHEET 6 AA1 6 SER A 76 TYR A 79 -1 O THR A 78 N GLY A 69 SHEET 1 AA2 3 VAL A 37 LYS A 42 0 SHEET 2 AA2 3 THR A 97 LEU A 102 -1 O MET A 100 N ILE A 39 SHEET 3 AA2 3 ALA A 87 ASP A 92 -1 N THR A 90 O PHE A 99 SHEET 1 AA3 4 THR B 25 GLN B 26 0 SHEET 2 AA3 4 VAL B 39 ARG B 44 -1 O ARG B 44 N THR B 25 SHEET 3 AA3 4 GLU B 90 ILE B 95 -1 O TYR B 91 N CYS B 43 SHEET 4 AA3 4 ARG B 86 SER B 87 -1 N SER B 87 O GLU B 90 SHEET 1 AA4 5 SER B 30 ALA B 33 0 SHEET 2 AA4 5 THR B 122 ILE B 126 1 O LYS B 123 N LEU B 31 SHEET 3 AA4 5 ASP B 105 GLN B 110 -1 N TYR B 106 O THR B 122 SHEET 4 AA4 5 SER B 54 GLN B 58 -1 N GLN B 58 O ASP B 105 SHEET 5 AA4 5 ILE B 64 ILE B 68 -1 O LEU B 67 N TRP B 55 SHEET 1 AA5 4 SER B 30 ALA B 33 0 SHEET 2 AA5 4 THR B 122 ILE B 126 1 O LYS B 123 N LEU B 31 SHEET 3 AA5 4 ASP B 105 GLN B 110 -1 N TYR B 106 O THR B 122 SHEET 4 AA5 4 THR B 117 PHE B 118 -1 O THR B 117 N GLN B 110 SHEET 1 AA6 5 ASN C 354 ILE C 358 0 SHEET 2 AA6 5 ASN C 394 ARG C 403 -1 O ALA C 397 N LYS C 356 SHEET 3 AA6 5 PRO C 507 GLU C 516 -1 O SER C 514 N TYR C 396 SHEET 4 AA6 5 GLY C 431 ASN C 437 -1 N ILE C 434 O VAL C 511 SHEET 5 AA6 5 THR C 376 CYS C 379 -1 N LYS C 378 O VAL C 433 SHEET 1 AA7 2 CYS C 391 PHE C 392 0 SHEET 2 AA7 2 VAL C 524 CYS C 525 -1 O VAL C 524 N PHE C 392 SHEET 1 AA8 2 LEU C 452 ARG C 454 0 SHEET 2 AA8 2 LEU C 492 SER C 494 -1 O GLN C 493 N TYR C 453 SSBOND 1 CYS A 41 CYS A 115 1555 1555 2.04 SSBOND 2 CYS B 43 CYS B 108 1555 1555 2.05 SSBOND 3 CYS C 336 CYS C 361 1555 1555 2.02 SSBOND 4 CYS C 379 CYS C 432 1555 1555 2.03 SSBOND 5 CYS C 391 CYS C 525 1555 1555 2.03 SSBOND 6 CYS C 480 CYS C 488 1555 1555 2.04 LINK ND2 ASN C 343 C1 NAG C 601 1555 1555 1.43 CISPEP 1 TYR B 114 PRO B 115 0 -22.34 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000